MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastrointestinal Cancers | MicrobiomeTrials← Back to trialsNCT07625735
MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastrointestinal Cancers
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-11-01Est. Completion: 2027-01-30
Enrollment target: 5,000 participants Other microbiome trials you might be interested in
Malignant Germ Cell TumorLung AdenocarcinomaGastric/Esophageal/Gastroesophageal Junction (GEJ) AdenocarcinomaUrothelial CarcinomaEndometrial AdenocarcinomaOvarian Adenocarcinoma
DBC-664-ONC-101 is a first-in-human Phase 1a/1b open-label, multicenter study to evaluate the safety, tolerability, PK, …
Denver, United StatesEst. completion Apr 1, 2030
Gastrointestinal Tumors
This is an open-label, multicenter, phase II study. The purpose of this study is to evaluate the safety, tolerability an…
Chongqing, China
Est. completion Aug 31, 2027